Developmental programing: Impact of testosterone on placental differentiation

52Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

Gestational testosterone treatment causes maternal hyperinsulinemia, intrauterine growth retardation (IUGR), low birth weight, and adult reproductive and metabolic dysfunctions. Sheep models of IUGR demonstrate placental insufficiency as an underlying cause of IUGR. Placental compromise is probably the cause of fetal growth retardation in gestational testosterone-treated sheep. This study tested whether testosterone excess compromises placental differentiation by its androgenic action and/or via altered insulin sensitivity. A comparative approach of studying gestational testosterone (aromatizable androgen) against dihydrotestosterone (non-aromatizable androgen) or testosterone plus androgen antagonist, flutamide, was used to determine whether the effects of testosterone on placental differentiation were programed by its androgenic actions. Co-treatment of testosterone with the insulin sensitizer, rosiglitazone, was used to establish whether the effects of gestational testosterone on placentome differentiation involved compromised insulin sensitivity. Parallel cohorts of pregnant females were maintained for lambing and the birth weight of their offspring was recorded. Placental studies were conducted on days 65, 90, or 140 of gestation. Results indicated that i) gestational testosterone treatment advances placental differentiation, evident as early as day 65 of gestation, and culminates in low birth weight, ii) placental advancement is facilitated at least in part by androgenic actions of testosterone and is not a function of disrupted insulin homeostasis, and iii) placental advancement, while helping to increase placental efficiency, was insufficient to prevent IUGR and low-birth-weight female offspring. Findings from this study may be of relevance to women with polycystic ovary syndrome, whose reproductive and metabolic phenotype is captured by the gestational testosterone-treated offspring.

References Powered by Scopus

Effect of in utero and early-life conditions on adult health and disease

3047Citations
N/AReaders
Get full text

The Developmental Origins of Adult Disease

1244Citations
N/AReaders
Get full text

Adult consequences of fetal growth restriction

744Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome

215Citations
N/AReaders
Get full text

Developmental programming, a pathway to disease

168Citations
N/AReaders
Get full text

Androgens in maternal vascular and placental function: Implications for preeclampsia pathogenesis

82Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Beckett, E. M., Astapova, O., Steckler, T. L., Veiga-Lopez, A., & Padmanabhan, V. (2014). Developmental programing: Impact of testosterone on placental differentiation. Reproduction, 148(2), 199–209. https://doi.org/10.1530/REP-14-0055

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 15

79%

Researcher 3

16%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 10

50%

Agricultural and Biological Sciences 7

35%

Nursing and Health Professions 2

10%

Environmental Science 1

5%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 103

Save time finding and organizing research with Mendeley

Sign up for free